Skip to main content
Top

Investigational New Drugs

Issue 5/2019

Content (29 Articles)

PRECLINICAL STUDIES

A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma

Y. Cai, Fei Wang, Q. Liu, Z. Li, D. Li, Z. Sun

PRECLINICAL STUDIES

The bispecific anti-CD3 × anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer

Huijun Zhao, Juan Ma, Ting Lei, Wanru Ma, Man Zhang

PRECLINICAL STUDIES

Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer

Eriko Yokoi, Seiji Mabuchi, Kotaro Shimura, Naoko Komura, Katsumi Kozasa, Hiromasa Kuroda, Ryoko Takahashi, Tomoyuki Sasano, Mahiru Kawano, Yuri Matsumoto, Michiko Kodama, Kae Hashimoto, Kenjiro Sawada, Tadashi Kimura

PRECLINICAL STUDIES

The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling

Juan Wang, Shumei Ma, Xiuhua Chen, Sanqi Zhang, Zhiyong Wang, Qibing Mei

PRECLINICAL STUDIES

Caffeic acid phenethyl ester exerts apoptotic and oxidative stress on human multiple myeloma cells

Elizabeth Hernandez Marin, Hana Paek, Mei Li, Yesung Ban, Marie Katie Karaga, Rangaiah Shashidharamurthy, Xinyu Wang

Open Access PRECLINICAL STUDIES

The role of oxidative stress in 63 T-induced cytotoxicity against human lung cancer and normal lung fibroblast cell lines

Malgorzata Kucinska, Helena Mieszczak, Hanna Piotrowska-Kempisty, Mariusz Kaczmarek, Walter Granig, Marek Murias, Thomas Erker

PRECLINICAL STUDIES

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

Weihua Hou, Qingyun Yuan, Xingxing Yuan, Yuxiong Wang, Wei Mo, Huijie Wang, Min Yu

Open Access PRECLINICAL STUDIES

The availability of drug by liposomal drug delivery

Evelien A. W. Smits, José A. Soetekouw, Ebel H. E. Pieters, Coen J. P. Smits, Nicolette de Wijs-Rot, Herman Vromans

PRECLINICAL STUDIES

Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells

Blair P. Curless, Nne E. Uko, Diane F. Matesic

PRECLINICAL STUDIES

MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells

Mariana Franzoni Maioral, Natália Marceli Stefanes, Álisson Bigolin, Gabriele Andressa Zatelli, Ana Cláudia Philippus, Miriam de Barcellos Falkenberg, Maria Cláudia Santos-Silva

Gastric Cancer PRECLINICAL STUDIES

MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer

Shaohua Ge, Haiyang Zhang, Ting Deng, Wu Sun, Tao Ning, Qian Fan, Yi Wang, Xinyi Wang, Qiumo Zhang, Zhengyang Zhou, Haiou Yang, Guoguang Ying, Yi Ba

Colorectal Cancer PRECLINICAL STUDIES

Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib

Titto Augustine, Radhashree Maitra, Jinghang Zhang, Jay Nayak, Sanjay Goel

Radioimmunotherapy PRECLINICAL STUDIES

Biodistribution, pharmacokinetics and radioimmunotherapy of 188Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice

Ya-Jen Chang, Chung-Li Ho, Kai-Hung Cheng, Wan-I Kuo, Wan-Chi Lee, Keng-Li Lan, Chih-Hsien Chang

Open Access Glioblastoma PRECLINICAL STUDIES

The cellular effects of novel triazine nitrogen mustards in glioblastoma LBC3, LN-18 and LN-229 cell lines

Rafał Krętowski, Danuta Drozdowska, Beata Kolesińska, Zbigniew Kamiński, Justyna Frączyk, Marzanna Cechowska-Pasko

PRECLINICAL STUDIES

In vitro and in vivo cytotoxic activity and human serum albumin interaction for a methoxy-styryl-thiosemicarbazone

Otávio Augusto Chaves, Isabela S. de Castro, Carla Marins Goulart, Myrtes S. S. Bellieny, José Carlos Netto-Ferreira, Juliana Echevarria-Lima, Aurea Echevarria

osteosarcoma PRECLINICAL STUDIES

Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma

Yi Luo, Anqi Zeng, Aiping Fang, Linjiang Song, Chen Fan, Chenjuan Zeng, Tinghong Ye, Hao Chen, Chongqi Tu, Yongmei Xie

Melanoma PRECLINICAL STUDIES

Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo

Svetlana Paskas, Emanuela Mazzon, Maria Sofia Basile, Eugenio Cavalli, Yousef Al-Abed, Mingzhu He, Sara Rakocevic, Ferdinando Nicoletti, Sanja Mijatovic, Danijela Maksimovic-Ivanic

Esophageal Cancer PRECLINICAL STUDIES

Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines

Viviane A. O Silva, Marcela N. Rosa, Olga Martinho, Amilcar Tanuri, João Paulo Lima, Luiz F. Pianowski, Rui M. Reis

Melanoma PRECLINICAL STUDIES

Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo

Juan Ma, Tengfei Shang, Pan Ma, Xin Sun, Jin Zhao, Ximing Sun, Man Zhang

Sarcoma PHASE I STUDIES

The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model

Narine Ghazaryan, Naira Movsisyan, Joana Catarina Macedo, Sara Vaz, Naira Ayvazyan, Luis Pardo, Elsa Logarinho

Prostate Cancer PHASE I STUDIES

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

Deaglan McHugh, Mario Eisenberger, Elisabeth I. Heath, Justine Bruce, Daniel C. Danila, Dana E. Rathkopf, Jarett Feldman, Susan F. Slovin, Banmeet Anand, Rong Chu, Jacqueline Lackey, Leonard Reyno, Emmanuel S. Antonarakis, Michael J. Morris

Open Access Solid Tumor PHASE I STUDIES

A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors

Toshihiko Doi, Takeshi Aramaki, Hirofumi Yasui, Kei Muro, Masafumi Ikeda, Takuji Okusaka, Yoshitaka Inaba, Kenya Nakai, Hiroki Ikezawa, Ryo Nakajima

PRECLINICAL STUDIES

Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters

Paul Berveiller, Olivier Mir, Séverine A. Degrelle, Vassilis Tsatsaris, Lise Selleret, Jean Guibourdenche, Danièle Evain-Brion, Thierry Fournier, Sophie Gil

Phase III Studies

The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States

Hiroki Nakayama, Naoki Matsumaru, Katsura Tsukamoto

Human antigen R and drug resistance in tumors

Fenghai Zhou, Fa Zhang, Chuan Zhou, Mengtian Liang, Zhonglin Cai, Haidi Lv, Wenjuan Li, Xupan Wei

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine